Manidipine structure
|
Common Name | Manidipine | ||
---|---|---|---|---|
CAS Number | 89226-50-6 | Molecular Weight | 610.699 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 722.0±60.0 °C at 760 mmHg | |
Molecular Formula | C35H38N4O6 | Melting Point | 125-128ºC | |
MSDS | N/A | Flash Point | 390.4±32.9 °C |
Use of ManidipineManidipine is a calcium channel blocker that is used clinically as an antihypertensive. Target: Calcium ChannelManidipine is a dihydropyridine calcium antagonist, which causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. Manidipine was well tolerated in clinical trials, with most adverse effects related to vasodilation [1]. Manidipine is a lipophilic, third-generation dihydropyridine calcium channel antagonist with a high degree of selectivity for the vasculature, thereby inducing marked peripheral vasodilation with negligible cardiodepression. manidipine represents a first-line treatment option for patients with essential mild-to-moderate hypertension [2]. Manidipine has neutral effects on glucose and lipid metabolism and is generally well tolerated. Manidipine thus represents a first-line option for lowering BP in patients with mild-to-moderate hypertension [3]. |
Name | 3-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
---|---|
Synonym | More Synonyms |
Description | Manidipine is a calcium channel blocker that is used clinically as an antihypertensive. Target: Calcium ChannelManidipine is a dihydropyridine calcium antagonist, which causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. Manidipine was well tolerated in clinical trials, with most adverse effects related to vasodilation [1]. Manidipine is a lipophilic, third-generation dihydropyridine calcium channel antagonist with a high degree of selectivity for the vasculature, thereby inducing marked peripheral vasodilation with negligible cardiodepression. manidipine represents a first-line treatment option for patients with essential mild-to-moderate hypertension [2]. Manidipine has neutral effects on glucose and lipid metabolism and is generally well tolerated. Manidipine thus represents a first-line option for lowering BP in patients with mild-to-moderate hypertension [3]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 722.0±60.0 °C at 760 mmHg |
Melting Point | 125-128ºC |
Molecular Formula | C35H38N4O6 |
Molecular Weight | 610.699 |
Flash Point | 390.4±32.9 °C |
Exact Mass | 610.279114 |
PSA | 116.93000 |
LogP | 5.46 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.601 |
Storage condition | -20°C Freezer |
Hazard Codes | Xi |
---|
~% Manidipine CAS#:89226-50-6 |
Literature: WO2011/23954 A2, ; Page/Page column 18 ; |
~77% Manidipine CAS#:89226-50-6 |
Literature: Meguro; Aizawa; Sohda; Kawamatsu; Nagaoka Chemical and Pharmaceutical Bulletin, 1985 , vol. 33, # 9 p. 3787 - 3797 |
~% Manidipine CAS#:89226-50-6 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 9 p. 3787 - 3797 |
~% Manidipine CAS#:89226-50-6 |
Literature: WO2011/23954 A2, ; |
~% Manidipine CAS#:89226-50-6 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 9 p. 3787 - 3797 |
~% Manidipine CAS#:89226-50-6 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 33, # 9 p. 3787 - 3797 |
2-[4-(Diphenylmethyl)-1-piperazinyl]ethylmethyl (±)-1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinecarboxylate |
2-[4-(diphenylmethyl)piperazin-1-yl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
MANIDIPINE: MANIDIPINE DIHYDROCHLORIDE |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl Methyl Ester |
1-diphenylmethyl-4-(2-hydroxyethyl)piperazine |
2-[4-(Diphenylmethyl)-1-piperazinyl]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate |
3-{2-[4-(diphenylMethyl)piperazin-1-yl]ethyl} 5-Methyl 2,6-diMethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Manidipine 6300 |
Manidipine |
UNII:6O4754US88 |
CV-4093,2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
Manidipine (Manyper) |
2-(4-(Diphenylmethyl)-1-piperazinyl)ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
(+/-)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester |
2-(4-Diphenylmethyl-1-piperazinyl)ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
2-(4-benzhydryl-1-piperazinyl)ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Franidipine |
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-(diphenylmethyl)-1-piperazinyl]ethyl methyl ester |